Cargando…
P1170: CAR-T THERAPY IS EFFECTIVE AND SAFE IN TREATING RELAPSED/REFRACTORY LYMPHOMA WITH MALIGNANT SEROUS CAVITY EFFUSION
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431107/ http://dx.doi.org/10.1097/01.HS9.0000971576.90319.a2 |
_version_ | 1785091121423056896 |
---|---|
author | Huang, Lefu Lu, Peihua |
author_facet | Huang, Lefu Lu, Peihua |
author_sort | Huang, Lefu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104311072023-08-17 P1170: CAR-T THERAPY IS EFFECTIVE AND SAFE IN TREATING RELAPSED/REFRACTORY LYMPHOMA WITH MALIGNANT SEROUS CAVITY EFFUSION Huang, Lefu Lu, Peihua Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431107/ http://dx.doi.org/10.1097/01.HS9.0000971576.90319.a2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Huang, Lefu Lu, Peihua P1170: CAR-T THERAPY IS EFFECTIVE AND SAFE IN TREATING RELAPSED/REFRACTORY LYMPHOMA WITH MALIGNANT SEROUS CAVITY EFFUSION |
title | P1170: CAR-T THERAPY IS EFFECTIVE AND SAFE IN TREATING RELAPSED/REFRACTORY LYMPHOMA WITH MALIGNANT SEROUS CAVITY EFFUSION |
title_full | P1170: CAR-T THERAPY IS EFFECTIVE AND SAFE IN TREATING RELAPSED/REFRACTORY LYMPHOMA WITH MALIGNANT SEROUS CAVITY EFFUSION |
title_fullStr | P1170: CAR-T THERAPY IS EFFECTIVE AND SAFE IN TREATING RELAPSED/REFRACTORY LYMPHOMA WITH MALIGNANT SEROUS CAVITY EFFUSION |
title_full_unstemmed | P1170: CAR-T THERAPY IS EFFECTIVE AND SAFE IN TREATING RELAPSED/REFRACTORY LYMPHOMA WITH MALIGNANT SEROUS CAVITY EFFUSION |
title_short | P1170: CAR-T THERAPY IS EFFECTIVE AND SAFE IN TREATING RELAPSED/REFRACTORY LYMPHOMA WITH MALIGNANT SEROUS CAVITY EFFUSION |
title_sort | p1170: car-t therapy is effective and safe in treating relapsed/refractory lymphoma with malignant serous cavity effusion |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431107/ http://dx.doi.org/10.1097/01.HS9.0000971576.90319.a2 |
work_keys_str_mv | AT huanglefu p1170carttherapyiseffectiveandsafeintreatingrelapsedrefractorylymphomawithmalignantserouscavityeffusion AT lupeihua p1170carttherapyiseffectiveandsafeintreatingrelapsedrefractorylymphomawithmalignantserouscavityeffusion |